MEDBOX | Toolbox Public Health

Orientaciones para la vigilancia de las variantes del SARS-CoV-2

World Health Organisation (WHO) (2021) C_WHO

Orientaciones provisionales 9 de agosto de 2021 El presente documento tiene por objeto describir un conjunto mínimo de actividades de vigilancia recomendadas a nivel nacional para detectar y supervisar la prevalencia relativa de las variantes del SRAS-CoV-2 y esbozar un conjunto de actividades para la caracterización y evaluación del riesgo que plantean estas variantes. También se ofrece un conjunto de indicadores para normalizar la vigilancia y la notificación pública de la circulación de variantes. El documento está dirigido principalmente a las autoridades de salud pública nacionales y subnacionales y a los socios que apoyan la aplicación de la vigilancia de las variantes del SRAS-CoV-

Tags: SARS-CoV-2, variant, Surveillance, public health authorities, prevalence, COVID-19,

Source: https://apps.who.int/iris/bitstream/hand

Руководство по эпидемиологическому надзору за вариантами SARS-CoV-2

World Health Organisation (WHO) (2021) C_WHO

Tags: SARS-CoV-2, variant, Surveillance, public health authorities, prevalence, COVID-19,

Source: https://apps.who.int/iris/bitstream/hand

Orientations pour la surveillance des variants du SARS-CoV-2

World Health Organisation (WHO) (2021) C_WHO

Orientations provisoires 9 août 2021 Le présent document vise à décrire un ensemble minimal d'activités de surveillance recommandées au niveau national pour détecter et surveiller la prévalence relative des variantes du SRAS-CoV-2 et à présenter un ensemble d'activités pour la caractérisation et l'évaluation du risque que présentent ces variantes. k posés par ces variants. Un ensemble d'indicateurs est également fourni pour normaliser la surveillance et la déclaration publique de la circulation des variants. Ce document est principalement destiné aux autorités de santé publique nationales et infranationales et aux partenaires qui soutiennent la mise en œuvre de la surveillance des variantes du SRAS-CoV-2

Tags: SARS-CoV-2, variant, Surveillance, public health authorities, prevalence, COVID-19,

Source: https://apps.who.int/iris/bitstream/hand

Guidance for surveillance of SARS-CoV-2 variants - Arabic version

World Health Organisation (WHO) (2021) C_WHO

This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators is also provided to standardize monitoring and public reporting of variant circulation. The document is primarily intended for national and sub-national public health authorities and partners who support implementation of surveillance for SARS-CoV-2 variant

Tags: SARS-CoV-2, variant, Surveillance, public health authorities, prevalence, COVID-19,

Source: https://apps.who.int/iris/bitstream/hand

Special Focus: Update on SARS-CoV-2 Variants of Interest and Variants of Concern

World Health Organization WHO (2021) C_WHO

Weekly epidemiological update on COVID-28 September 2021

Tags: covax, Vaccines, COVID-19, Supply, Access, variants, virus variants, mutation, Brazil, South Africa, Great Britain, Delta, Beta, Gamma,

Source: https://www.who.int/docs/default-source/

Variants du virus et leurs effets sur les vaccins contre la COVID-19

Organisation Mondiale de la Santé OMS (2021) C_WHO

Cet article fait partie d’une série de notes explicatives sur la mise au point et la distribution de vaccins.

Tags: Vaccination, effects, virus variants, COVID-19, SARS-CoV-2,

Source: https://www.who.int/fr/news-room/feature

SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020–March 2021

Kleynhans, J.; et al. (2021) C_CDC

EID Journal , Volume 27, no.12 , Dec. 2021. Early Release Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections may be underestimated because of limited access to testing. We measured SARS-CoV-2 seroprevalence in South Africa every 2 months during July 2020–March 2021 in randomly selected household cohorts in 2 communities. We compared seroprevalence to reported laboratory-confirmed infections, hospitalizations, and deaths to calculate infection–case, infection–hospitalization, and infection–fatality ratios in 2 waves of infection. Post–second wave seroprevalence ranged from 18% in the rural community children <5 years of age, to 59% in urban community adults 35–59 years of age. The second wave saw a shift in age distribution of case-patients in the urban community (from persons 35–59 years of age to persons at the extremes of age), higher attack rates in the rural community, and a higher infection–fatality ratio in the urban community. Approximately 95% of SARS-CoV-2 infections were not reported to national surveillance

Tags: mortality, excess mortality, COVID-19, South Africa, laboratory-confirmed, Surveillance,

Source: https://wwwnc.cdc.gov/eid/article/27/12/

Tenue de rassemblements pendant la pandémie de COVID-19 : note d'orientation de l'OMS, 2 août 2021

Organisation mondiale de la Santé OMS (2021) C_WHO

Les rassemblements sont des événements caractérisés par la con-centration de personnes dans un lieu donné, dans un but précis sur une période de temps déterminée. Le but de cette note d’orientation est de présenter la position et les orientations de l’OMS concernant la tenue de rassemblements pendant la pandémie de COVID-19. Elle s’adresse aux respons-ables des politiques. Les informations proviennent des publications de l’OMS et d’un examen des données probantes extraites de la littérature scientifiq

Tags: mass gathering, Quarantine, Outbreak Control, nCOV, COVID-19,

Source: https://apps.who.int/iris/handle/10665/3

World Health Organization WHO (2021) CC

Tags: SARS-CoV-2, variant, Surveillance, public health authorities, prevalence, COVID-19,

Source: https://apps.who.int/iris/rest/bitstream

Actualización Epidemiológica: Incremento de la variante delta y su impacto potencial en la región de las Américas - 8 de agosto de 2021

Pan American Health Organisation PAHO (2021) C_WHO

Tags: situation update, Latin America, virus variants, delta, covid-19,

Source: https://reliefweb.int/sites/reliefweb.in

	Orientaciones para la vigilancia de las variantes del SARS-CoV-2 World Health Organisation (WHO) (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX Orientaciones provisionales 9 de agosto de 2021 El presente documento tiene por objeto describir un conjunto mínimo de actividades de vigilancia recomendadas a nivel nacional para detectar y supervisar la prevalencia relativa de las variantes del SRAS-CoV-2 y esbozar un conjunto de actividades para la caracterización y evaluación del riesgo que plantean estas variantes. También se ofrece un conjunto de indicadores para normalizar la vigilancia y la notificación pública de la circulación de variantes. El documento está dirigido principalmente a las autoridades de salud pública nacionales y subnacionales y a los socios que apoyan la aplicación de la vigilancia de las variantes del SRAS-CoV- Tags: SARS-CoV-2, variant, Surveillance, public health authorities, prevalence, COVID-19, Source: https://apps.who.int/iris/bitstream/hand
	Руководство по эпидемиологическому надзору за вариантами SARS-CoV-2 World Health Organisation (WHO) (2021) C_WHO View PDF(1) Download (1) Add to my MEDBOX Временные рекомендации 9 августа 2021 г. Цель данного документа - описать минимальный набор мероприятий по эп��днадзору, рекомендуемых на национальном уровне для выявления и мониторинга относительной распространенности вариантов SARS-CoV-2, и наметить набор мероприятий для характеристики и оценки риска, создаваемого этими вариантами. Также приводится набор показателей для стандартизации мониторинга и публичной отчетности о циркуляции вариантов. Документ предназначен в первую очередь для национальных и субнациональных органов здравоохранения и партнеров, поддерживающих внедрение эпиднадзора за вариантами SARS-CoV-2 Tags: SARS-CoV-2, variant, Surveillance, public health authorities, prevalence, COVID-19, Source: https://apps.who.int/iris/bitstream/hand
	Orientations pour la surveillance des variants du SARS-CoV-2 World Health Organisation (WHO) (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX Orientations provisoires 9 août 2021 Le présent document vise à décrire un ensemble minimal d'activités de surveillance recommandées au niveau national pour détecter et surveiller la prévalence relative des variantes du SRAS-CoV-2 et à présenter un ensemble d'activités pour la caractérisation et l'évaluation du risque que présentent ces variantes. k posés par ces variants. Un ensemble d'indicateurs est également fourni pour normaliser la surveillance et la déclaration publique de la circulation des variants. Ce document est principalement destiné aux autorités de santé publique nationales et infranationales et aux partenaires qui soutiennent la mise en œuvre de la surveillance des variantes du SRAS-CoV-2 Tags: SARS-CoV-2, variant, Surveillance, public health authorities, prevalence, COVID-19, Source: https://apps.who.int/iris/bitstream/hand
	Guidance for surveillance of SARS-CoV-2 variants - Arabic version World Health Organisation (WHO) (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators is also provided to standardize monitoring and public reporting of variant circulation. The document is primarily intended for national and sub-national public health authorities and partners who support implementation of surveillance for SARS-CoV-2 variant Tags: SARS-CoV-2, variant, Surveillance, public health authorities, prevalence, COVID-19, Source: https://apps.who.int/iris/bitstream/hand
	Special Focus: Update on SARS-CoV-2 Variants of Interest and Variants of Concern World Health Organization WHO (2021) C_WHO View PDF(22) Download (9) Add to my MEDBOX Weekly epidemiological update on COVID-28 September 2021 Tags: covax, Vaccines, COVID-19, Supply, Access, variants, virus variants, mutation, Brazil, South Africa, Great Britain, Delta, Beta, Gamma, Source: https://www.who.int/docs/default-source/
	Variants du virus et leurs effets sur les vaccins contre la COVID-19 Organisation Mondiale de la Santé OMS (2021) C_WHO Open external link (24) Add to my MEDBOX Cet article fait partie d’une série de notes explicatives sur la mise au point et la distribution de vaccins. Tags: Vaccination, effects, virus variants, COVID-19, SARS-CoV-2, Source: https://www.who.int/fr/news-room/feature
	SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020–March 2021 Kleynhans, J.; et al. (2021) C_CDC Open external link (48) Add to my MEDBOX EID Journal , Volume 27, no.12 , Dec. 2021. Early Release Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections may be underestimated because of limited access to testing. We measured SARS-CoV-2 seroprevalence in South Africa every 2 months during July 2020–March 2021 in randomly selected household cohorts in 2 communities. We compared seroprevalence to reported laboratory-confirmed infections, hospitalizations, and deaths to calculate infection–case, infection–hospitalization, and infection–fatality ratios in 2 waves of infection. Post–second wave seroprevalence ranged from 18% in the rural community children <5 years of age, to 59% in urban community adults 35–59 years of age. The second wave saw a shift in age distribution of case-patients in the urban community (from persons 35–59 years of age to persons at the extremes of age), higher attack rates in the rural community, and a higher infection–fatality ratio in the urban community. Approximately 95% of SARS-CoV-2 infections were not reported to national surveillance Tags: mortality, excess mortality, COVID-19, South Africa, laboratory-confirmed, Surveillance, Source: https://wwwnc.cdc.gov/eid/article/27/12/
	Tenue de rassemblements pendant la pandémie de COVID-19 : note d'orientation de l'OMS, 2 août 2021 Organisation mondiale de la Santé OMS (2021) C_WHO View PDF(1) Download (1) Add to my MEDBOX Les rassemblements sont des événements caractérisés par la con-centration de personnes dans un lieu donné, dans un but précis sur une période de temps déterminée. Le but de cette note d’orientation est de présenter la position et les orientations de l’OMS concernant la tenue de rassemblements pendant la pandémie de COVID-19. Elle s’adresse aux respons-ables des politiques. Les informations proviennent des publications de l’OMS et d’un examen des données probantes extraites de la littérature scientifiq Tags: mass gathering, Quarantine, Outbreak Control, nCOV, COVID-19, Source: https://apps.who.int/iris/handle/10665/3
	Guidance for surveillance of SARS-CoV-2 variants: Interim guidance, 9 August 2021 World Health Organization WHO (2021) CC View PDF(3) Download (2) Add to my MEDBOX This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators is also provided to standardize monitoring and public reporting of variant circulation. The document is primarily intended for national and sub-national public health authorities and partners who support implementation of surveillance for SARS-CoV-2 variant Tags: SARS-CoV-2, variant, Surveillance, public health authorities, prevalence, COVID-19, Source: https://apps.who.int/iris/rest/bitstream
	Actualización Epidemiológica: Incremento de la variante delta y su impacto potencial en la región de las Américas - 8 de agosto de 2021 Pan American Health Organisation PAHO (2021) C_WHO View PDF(2) Download (2) Add to my MEDBOX Tags: situation update, Latin America, virus variants, delta, covid-19, Source: https://reliefweb.int/sites/reliefweb.in

About MEDBOX

MEDBOX Video Series